It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2003.
2003 | Chennai, Tamil Nadu, India | ActiveWinbro Pharma Private Limited, a active private limited company, was established on 05 December 2003 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN2003PTC052087. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.80 M.
It upholds a compliant status. Its leadership includes Renganathan Pappu Reddiar (Director), Malarselvi Renganathan (Director). Past directors included Pandurangan Balakrishnan, Perumal Asaithambi, Thuvaarakkesh Ramanathan. It holds ₹0.56 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 41, 3Rd Street, V.G.P Layout Injambakkam, Chennai, Tamil Nadu, 600041.
U24231TN2003PTC052087
052087
05 December 2003
₹1.00 M
₹0.80 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Winbro Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Renganathan Pappu Reddiar | Director | 05 Dec 2003 | Current |
| Malarselvi Renganathan | Director | 02 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2019 | Past |
| Pramod Abcsdd | Director | 01 Apr 2018 | Past |
| Pramod Abcsdd | Director | 05 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Winbro Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.63% decrease. The company also saw a substantial fall in profitability, with a 368.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 140.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Winbro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹555,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2022 | Hdfc Bank Limited | ₹0.56 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Winbro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Winbro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winbro Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Winbro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Winbro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.56 M with Charge ID 100566499 was registered on 12 Apr 2022. was completed.
Malarselvi Renganathan was appointed as a Director was appointed as a Director on 02 Nov 2020 & has been associated with this company since 5 years 29 days . was recorded as a recent event.
Renganathan Pappu Reddiar was appointed as a Director was appointed as a Director on 05 Dec 2003 & has been associated with this company since 21 years 11 months . was recorded as a recent event.
Progress on Winbro Pharma Private Limited was registered on 05 Dec 2003 with Roc Chennai & aged 21 years 11 months as per MCA records. was documented.
The CIN of Winbro Pharma Private Limited is U24231TN2003PTC052087.
Winbro Pharma Private Limited is headquartered at 41, 3Rd Street, V.G.P Layout Injambakkam, Chennai, Tamil Nadu, 600041.
Winbro Pharma Private Limited was incorporated on 05 December 2003.
The current directors of Winbro Pharma Private Limited are
The primary industry of Winbro Pharma Private Limited is Manufacturing.
Winbro Pharma Private Limited is unlisted.
The authorized capital of Winbro Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.80 M.
The compliance status of Winbro Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX